Read More Analyst Ratings Initiation News Price Target Goldman Sachs Initiates Coverage On Toast with Neutral Rating, Announces Price Target of $52 By Benzinga Newsdesk Today, 4:44 PM Goldman Sachs analyst Will Nance initiates coverage on Toast (NYSE:TOST) with a Neutral rating and announces Price Target of $52. TOST
Read More Analyst Ratings Initiation News Price Target Benchmark Initiates Coverage On Kirkland’s with Buy Rating, Announces Price Target of $30 By Benzinga Newsdesk Today, 4:44 PM Benchmark initiates coverage on Kirkland's (NASDAQ:KIRK) with a Buy rating and announces Price Target of $30. KIRK
Read More Earnings Guidance Movers News Small Cap Trading Ideas AerSale Stock Gains As Revenue Tops Consensus, Backs FY21 Outlook By Akanksha Today, 4:44 PM AerSale Corp (NASDAQ:ASLE) reported second-quarter revenue growth of 102.7% year-over-year to $91.91 million, beating the consensus of $77.28 million. Revenues included… ASLE
Read More Biotech General Health Care Long Ideas M&A Movers News Penny Stocks Small Cap Trading Ideas Amneal’s $83M Saol Acquisition Deal Expands Its Neurology Presence Into Spasticity By Vandana Singh Today, 4:44 PM Amneal Pharmaceuticals Inc (NYSE: AMRX) has agreed to acquire Saol's Baclofen franchise, including Lioresal, Lyvispah, and a pipeline product under development AMRX